ImmunityBio, Inc. IBRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Other revenues | $39K+388% | $13K-96.2% | $281K+84.9% | $4K-93.0% | $8K-80.0% | |
| Product revenue, net | $44.17M+168% | $38.27M+431% | $31.78M+434% | $26.42M+2,569% | $16.51M— | |
| Revenue by Geography | ||||||
| Europe | $24K— | $16K-95.2% | $262K+118% | $0-100% | $0-100% | |
| U.S. | $44.18M+167% | $38.27M+430% | $31.8M+431% | $26.43M+2,553% | $16.52M+110,013% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ImmunityBio, Inc. break its business down?
- ImmunityBio, Inc. (IBRX) reports total revenue by product across 2 parts — Other revenues and Product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does ImmunityBio, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ImmunityBio, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
